As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.
Canadian prime minister Justin Trudeau has pledged an extra C$1.1 billion to bolster vaccine research, clinical trials and national testing to fight COVID-19.
A call for research how to model and understand the spread of COVID-19, its transmission and prevention in the society. Computer sciences and engineering proposals will not be accepted.
Amount
$55.000 - $80.000 (U.S. dollars) per year
Agency or Funder
United States–Israel Binational Science Foundation
Projects should focus on epidemiology, clinical management, prevention and social sciences.
Amount
£1M per award
Agency or Funder
UK Department of Health and Social Care and Medical Research Council
Eligibility (if available)
Applications are particularly encouraged from LMIC principal investigators, as well as principal investigators based in the UK working in equitable partnerships with LMIC investigators. Applicants must have a relevant academic affiliation to an eligible institution in an LMIC or the UK.
This call aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and to increase research and response capacity.
Amount
Up to £2M
Agency or Funder
Wellcome Trust & UK Department for International Development (DFID)
Eligibility (if available)
PhD plus significant postdoctoral experience in an academic research organisation, a not-for-profit or government body, a private sector organisation
Support for regional projects that use genomics to address specific, short-term needs of industry, not-for-profit bodies and the public sector in relation to COVID-19 through research in collaboration with these organisations.
Amount
Up to 250,000 CAD per region, total 1.5M CAD
Agency or Funder
Genome British Columbia
Eligibility (if available)
Regional organisations and researchers from Genome Centres
An invitation to contribute to the understanding of the COVID-19 epidemic in Bolivia and its impact on mental health, food security, the economy, and education.
Amount
Decided on a case by case basis
Agency or Funder
Universidad Autónoma Gabriel René Moreno
Eligibility (if available)
Researchers at the Universidad Autónoma Gabriel René Moreno
Research proposals around the world relating to the COVID-19 virus will be matched with appropriate high-performance computing facilities from among the consortium partners.
Agency or Funder
White House Office of Science and Technology Policy, Department of Energy and IBM
Proposals must be appropriate to the emergency situation and, therefore, allow immediate implementation and start-up in the National Health System, with concrete, early results applicable to the current situation.
DOE is asking for your ideas about how it and the National Labs might contribute resources to help address COVID-19 through science and technology efforts and collaborations.
Foresighted, basic, retrospective and evidence-based joint research surrounding four aspects in the epidemic prevention and control in terms of responses and management, governance mechanism, economic impact and countermeasures, and social governa
Targeted on four priorities identified by the WHO : 1) epidemiological and translational studies; 2) the pathophysiology of the disease (not including vaccines); 3) infection prevention and control measures in the healthcare setting (including the
Amount
€3M
Agency or Funder
French Agence Nationale de la Recherche
Eligibility (if available)
Scientists from research institutes/organizations or company with French headquarters
Any aspect of coronavirus research. Applicants may request up to 300,000 francs for projects lasting up to 24 months. Bigger grants are conceivable, provided the applicant has good reasons for requesting a higher amount.
Funding for universities, technologists and researchers with innovative proposals, including seed funding, to provide solutions applicapel to the COVID-19 pandemic.
A call for R&D projects that can quickly contribute to improving the response of health systems to the impact of COVID-19, contributing to better patient management and the implementation of public health measures.
Part of the third phase of the PIPE programme, aimed at Innovative Research for SMEs. Its objective is to support research for SMEs which have conducted innovative research in the past.